Natco Pharma gets USFDA tentative approval

Image
Capital Market
Last Updated : Mar 19 2014 | 12:03 AM IST

For Oseltamivir Phosphate Capsules

Natco Pharma has received tentative approval of Oseltamivir Phosphate Capsules USP, 30mg (base), 45 mg (base) and 75 mg (base) by the United States Food & Drug Administration (USFDA)

Powered by Capital Market - Live News

More From This Section

First Published: Mar 18 2014 | 11:31 AM IST

Next Story